Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,397,881 | 4,397,881 | 0 | $81.45M | $84.31M | 77.49% | +$2.86M |
| Kura Oncology, Inc.(KURA) | 1,849,947 | 1,726,882 | -123,065 | $36.15M | $15.04M | 13.83% | -$21.11M |
| Lyell Immunopharma, Inc.(LYEL) | 8,325,000 | 8,325,000 | 0 | $11.49M | $5.33M | 4.90% | -$6.16M |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | $7.08M | $4.12M | 3.79% | -$2.96M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 875,000 | 0 | -875,000 | $16.84M | $0 | — | -$16.84M |